Ask Finn← Discover
YOUR MONEY

Oil at $100, Surging Yields, and a Looming Fed Hike Rattle Wall Street — But Two Stocks Stand Out

By Jordan Hayes · Monday, September 14, 2026
Finn's Take· TL;DR
  • Oil surged past $100/barrel while Treasury yields hit 2023 highs, pressuring stocks as Fed signals likely September rate hike.
  • Fed hike odds jumped to 88% after core CPI exceeded expectations, reversing months of rate-cut expectations and hurting growth stocks.
  • Apple and Moderna buck market weakness with strong technical setups, as stock-picking trumps broad index exposure in high-dispersion environment.
See this from any side — with sources:
Left takeNeutralRight take

A Brutal Week for Stocks as Multiple Pressures Converge

Wall Street just endured one of its most punishing stretches in years, and the pressure isn't letting up. Despite Friday's bounce, the stock market had a tough week amid $100 oil prices and surging Treasury yields. The combination of energy shock, rising borrowing costs, and a Federal Reserve that appears ready to raise rates has left investors scrambling for cover — though a handful of names are holding up remarkably well.

Major indexes sat in the penalty box a fourth straight session Thursday as U.S. oil topped $100 per barrel for the first time since May, and the 10-year Treasury note yield hit its highest point since late 2023. The Treasury's $6 billion buyback of longer-term debt, designed to ease yields, had no appreciable impact, and the Dow Jones Industrial Average is down 2.5% since last Friday while crude is up 8%. For everyday investors with retirement accounts or broad index funds, that's a painful one-week swing.

The Fed Is Back in the Hot Seat

Markets are now pricing in a meaningful probability of a 25-basis-point rate hike — a dramatic reversal from just months ago when economists anticipated rate cuts. Fed Chair Kevin Warsh's unexpectedly hawkish Jackson Hole address, combined with persistently elevated oil prices and sticky inflation readings, has fundamentally shifted the policy outlook. The next FOMC meeting is scheduled for September 15–16, 2026 — meaning a decision could come as early as Tuesday.

August core CPI rose 0.3% month over month, above the 0.2% economists expected, while headline inflation reached 3.4% year over year, keeping price pressures well above the Fed's 2% target. At the same time, the surge in crude oil and fuel prices has raised concerns that energy costs could feed back into broader inflation. Two drivers have lowered the bar for a September hike: continued supply-chain shocks tied to the ongoing Iran conflict that are keeping energy costs elevated, and increased investor doubt about the Fed's willingness to keep inflation contained after it left rates unchanged in July.

Odds of a Federal Reserve rate hike rose to 88% after the CPI data, up from about 71% the day prior, according to the CME FedWatch Tool. That's a stunning shift in sentiment and helps explain why bond yields have been climbing so aggressively — making stocks, especially growth stocks, a harder sell.

Two Stocks Bucking the Trend

Not everything is getting crushed. While broad indexes struggle, Apple and Moderna have emerged as rare bright spots. Both Apple and Moderna have cleared critical pivot thresholds, registering verified buy triggers on institutional tracking models. Moderna is drawing speculative momentum, while Apple acts as a safe haven against macroeconomic instability.

Apple staged its fall product event on September 9, 2026, and the stock is already positioning for the next leg. Apple has been a momentum name in 2026, with shares up 16.31% year to date and 35.06% over the trailing year, though the stock cooled off 2.96% in the week leading into the launch. As for Moderna, the biotech flashed a major technical buy trigger heading into the weekend following prolonged base consolidation. The biotech sector has absorbed defensive rotation flows as investors hunt for idiosyncratic growth detached from standard industrial cycles.

What This Means Going Forward

Index weakness driven by surging bond yields and crude prices creates severe dispersion. While passive benchmarks like the Dow get dragged down by cyclical and industrial names, capital concentrates inside liquid leaders like Apple and high-beta turnarounds like Moderna that possess independent catalysts. In other words, this is no longer a market where a rising tide lifts all boats — stock-picking matters more than it has in years.

The expected hike is not seen as the start of an aggressive tightening cycle, but rather as a measured move — a one-and-done recalibration to restore credibility. Still, with oil near triple digits, inflation still above target, and yields at multi-year highs, the path forward for the broader market remains bumpy. Investors who can identify the few companies strong enough to defy the macro headwinds may be the ones who come out ahead.

Have a question about this story?
Ask Finn — answers grounded in this article, from any viewpoint.